|
|
Volumn 32 Suppl 2, Issue , 2009, Pages
|
|
Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity or mortality? No.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ALPHA GLUCOSIDASE;
ANTIDIABETIC AGENT;
ENZYME INHIBITOR;
GLICLAZIDE;
METFORMIN;
SULFONYLUREA DERIVATIVE;
CARDIOVASCULAR DISEASE;
DIABETIC ANGIOPATHY;
DISEASE COURSE;
DRUG ANTAGONISM;
HUMAN;
MORBIDITY;
MORTALITY;
NOTE;
ORAL DRUG ADMINISTRATION;
PREDICTION AND FORECASTING;
ADMINISTRATION, ORAL;
ALPHA-GLUCOSIDASES;
CARDIOVASCULAR DISEASES;
DIABETIC ANGIOPATHIES;
DISEASE PROGRESSION;
ENZYME INHIBITORS;
GLICLAZIDE;
HUMANS;
HYPOGLYCEMIC AGENTS;
METFORMIN;
MORBIDITY;
PREDICTIVE VALUE OF TESTS;
SULFONYLUREA COMPOUNDS;
THIAZOLIDINEDIONES;
MLCS;
MLOWN;
|
|
EID: 75549085570
PISSN: None
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc09-s335 Document Type: Note |
|
Times cited : (13)
|
|
References (40)
|
